Key result
Stage 3 CKD is linked to reduced retinal microcirculation in diabetic patients.
Why the study?
The study investigated the effect of renal dysfunction categorized by chronic kidney disease stage on retinal microcirculation and retinal artery caliber in diabetic patients, particularly in the early stages of retinopathy and nephropathy.
Is chronic kidney disease stage associated with decreased retinal microcirculation in patients with diabetes?
Cross-Sectional (n=115)
Is chronic kidney disease stage associated with decreased retinal microcirculation in patients with diabetes?
Effect estimate: MBR: β = -0.257; TRFI: β = -0.316
p-value: p=0.031 for MBR; 0.015 for TRFI
In diabetic patients, impaired renal function (stage 3 CKD) is independently associated with decreased retinal blood flow, highlighting a link between early nephropathy and microvascular changes.
Stage 3 CKD may flag retinal hypoperfusion in diabetes; leaves open causal links and need for longitudinal studies.
This study investigated the effect of renal dysfunction categorized by the stage of chronic kidney disease (CKD) on the retinal microcirculation assessed by laser speckle flowgraphy (LSFG) and retinal artery caliber measured by adaptive optics imaging in diabetic patients particularly the early stage of retinopathy and nephropathy. We divided the patients with diabetes into three groups based on the CKD stage (non-CKD (n = 54); CKD stage 1 + 2 (n = 20); CKD stage 3 (n = 41)). The mean blur rate (MBR) of the stage 3 CKD group was significantly lower than that of the no-CKD group (p < 0.015). The total retinal flow index (TRFI) in the stage 3 CKD group was significantly lower than that of the no-CKD group (p < 0.002). Multiple regression analysis demonstrated that CKD stage was independently associated with MBR (β = −0.257, p = 0.031) and TRFI (β = −0.316, p = 0.015). No significant differences were observed in external diameter, lumen diameter, wall thickness, and wall to lumen ratio among the groups. These results indicated that the ONH MBR and TRFI as assessed by LSFG decreases in diabetic patients with stage 3 CKD, but the arterial diameter measured by adaptive optics imaging does not change, suggesting that impaired renal function may be associated with decreased retinal blood flow in early-stage diabetic retinopathy.
No takes yet. Share an insight, caveat, or question.
Iwase et al. (2023) conducted a cross-sectional in Diabetes and Chronic Kidney Disease (n=115). Stage 3 Chronic Kidney Disease vs. No CKD was evaluated on Mean blur rate (MBR) and total retinal flow index (TRFI) (MBR: β = -0.257; TRFI: β = -0.316, p=0.031 for MBR; 0.015 for TRFI). Stage 3 chronic kidney disease was independently associated with decreased mean blur rate (β = -0.257, p=0.031) and total retinal flow index (β = -0.316, p=0.015) in diabetic patients.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: